
Sign up to save your podcasts
Or


Dr William J Gradishar from Northwestern Medicine Feinberg School of Medicine in Chicago, Illinois, Dr Virginia Kaklamani from UT Health San Antonio MD Anderson Cancer Center in Texas, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Seth Wander from Massachusetts General Hospital in Boston, discuss key findings and practical considerations with ovarian function suppression for hormone receptor-positive breast cancer.
By Dr. Neil Love4.4
6262 ratings
Dr William J Gradishar from Northwestern Medicine Feinberg School of Medicine in Chicago, Illinois, Dr Virginia Kaklamani from UT Health San Antonio MD Anderson Cancer Center in Texas, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Seth Wander from Massachusetts General Hospital in Boston, discuss key findings and practical considerations with ovarian function suppression for hormone receptor-positive breast cancer.

138 Listeners

323 Listeners

498 Listeners

30 Listeners

76 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

121 Listeners

57 Listeners

294 Listeners

3,361 Listeners

205 Listeners

515 Listeners

59 Listeners

193 Listeners

0 Listeners